Official registry condition

Hypertension peptide trials

6 selected ClinicalTrials.gov records carrying the official condition label Hypertension. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

6 selected records.

Connected peptides

4 profiles.

Registry update years

2015–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses2

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 128 selected PubMed records and 78 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hypertension unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00223717

PeptideScanner retained ClinicalTrials.gov record NCT00223717 at 2026-11-16T01:33:21.554Z. Its registry update date was 2017-10-13, and PeptideScanner's reviewed identity mapping was desmopressin.

PeptideScanner change date
November 16, 2026
Cited source date
October 13, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01413542

PeptideScanner retained ClinicalTrials.gov record NCT01413542 at 2026-11-16T01:39:41.882Z. Its registry update date was 2015-11-04, and PeptideScanner's reviewed identity mapping was nesiritide.

PeptideScanner change date
November 16, 2026
Cited source date
November 4, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01977859

PeptideScanner retained ClinicalTrials.gov record NCT01977859 at 2026-11-16T01:39:41.882Z. Its registry update date was 2018-02-14, and PeptideScanner's reviewed identity mapping was nesiritide.

PeptideScanner change date
November 16, 2026
Cited source date
February 14, 2018
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →